Dr Catherine Bladen, Scientific Officer & VP Technical Development & Innovation at Vector Labs and a cancer scientist based at The Wilton Centre, never imagined that her professional knowledge would become so deeply personal.

In September 2025, her mother, Rosemary Hill, aged 78, was diagnosed with an inoperable glioblastoma. What followed was a rapid, devastating journey that exposed the limitations of current brain tumour treatments and strengthened Catherine’s determination to advocate for personalised medicine and greater investment research into brain tumours.

Rosie was diagnosed and given three to six months to live.

Rosie, is also our colleague here at Absolute Antibody/Vector Labs. As the Human Resources Manager for the Wilton site she was still working right up until her diagnosis.

One in three people in the UK knows someone affected by a brain tumour. This disease is indiscriminate; it can affect anyone at any age. What’s more, brain tumours continue to kill more children and adults under the age of 40 than any other cancer yet, to date, just 1% of the national spend on cancer research has been allocated to this devastating disease since records began in 2002.

Brain Tumour Research is determined to change this and we are determined to help by fundraising as much money as possible.

Please help us smash our target!